How drugs act? Flashcards

(36 cards)

1
Q

What are the 5 major protein targets for drug action?

A
  1. Receptors
  2. Enzymes
  3. Specific Circulating Plasma Proteins
  4. Carrier Molecules (Transporters)
  5. Ion Channels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
 Protein molecule which function 
to recognize and respond to 
endogenous chemical signals
• recognize/bind specific endogenous 
ligands
• may also recognize/bind xenobiotics
 Classified based on ligands
 Grouped into 4 major 
superfamilies
A

Receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 4 superfamilies of receptors?

A
  • Ligand-Gated Ion Channels
  • G-Protein Coupled Receptors
  • Kinase-Linked & Related Receptors
  • Nuclear Receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How many subunits are found in ligand-gated ion channels?

A

4-5 subunits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which subfamily of receptors form dimers?

A

Kinase-Linked

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

variation may arise from ______:

  • single gene can give rise to more than one receptor isoform
  • splicing can result in inclusion or deletion of one or more mRNA coding regions giving rise to short or long forms of protein
  • big role in G-protein coupled receptors
A

alternative mRNA splicing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

• share structural features with voltage-
gated ion channels
• “ionotropic” receptors

A

 Ligand-Gated Ion Channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

— nicotinic acetylcholine receptor (nAChR)
— gamma-aminobutyric acid type A receptor
(GABAA)
* inhibitory neurotransmitter
— glutamate receptors [N-methyl-D-aspartate
(NMDA), a-amino-3-hydroxy-5-methylisoxazole-4-propionic
acid (AMPA), and kainate types]
* excitatory neurotransmitter

are examples of what subfamily of receptor?

A

Ligand-gated ion channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

— best characterized of all cell-surface receptors
— pentamer: four different polypeptide
subunits
* 2 a, 1 b, 1 g, and 1 d, MW from 43K-50K each
* each subunit crosses plasma membrane 4 times
— acetylcholine binds sites on a subunits
— conformational change occurs
— transient opening of central aqueous channel
— Na+ flow from outside to inside cell
* down electro-chemical gradient
— cell depolarizes
— all occurs in milliseconds

A

• nAChR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  • largest superfamily of receptors
  • “metabotropic” receptors
  • 7 transmembrane spanning domains
A

 G-Protein Coupled Receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

• The following are examples of _____ receptors:
— muscarinic acetylcholine receptor (mAChR)
— opioid receptors (m, k, d)
— gamma-aminobutyric acid type B receptor (GABAB)
— serotonergic receptors (5-hydroxytryptamine or 5-HT, 1-7 types)
— adrenergic receptors (a and b types)
— angiotensin II receptors (1, 2, 3, 4 types)
— endothelin receptors (A, B, C types)
— histamine receptors (1, 2, 3 types)
— photon receptors (retinal rod and cone)

A

 G-Protein Coupled Receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

______ of Opioid Receptors
— heroin, morphine, oxycodone,
hydrocodone

A

Agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

______ of Opioid
Receptors
— naloxone, naltrexone

A

• Competitive Antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

— activation of GPCR is normally a result of diffusible ligand in solution acting on a receptor
— but GPCR receptor activation can occur as a result of protease activation
* protease cleaves off part of N-terminal domain of receptor
* “tethered agonist”: remaining attached domain is free to interact with ligand-binding domain
— examples:
* thrombin: a protease involved in blood clotting activates PAR
* PAR-2 is activated by a protease released from mast cells following degranulation

A

• Protease Activated Receptors (PAR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
— applicable to all GPCRs
— occurs via 2 main mechanisms
* receptor phosphorylation
* receptor internalization
— example:
* b-adrenergic receptors
* b-arrestin phosphorylates receptor 
reducing receptor affinity for G-proteins
* receptor can then be internalized
* all is rapidly reversible
A

• Desensitization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the 3 ways a GPCR can be desensitized?

A

Phosphorylation
Internalization in lysosome
Endocytosis

17
Q

— involved mainly in events controlling cell growth and differentiation
— act indirectly by regulating gene transcription
— signal transduction generally involves dimerization of two receptor molecules followed by autophosphorylation of tyrosine residues
— all have large extracellular ligand-binding domain connected via single membrane spanning domain to an intracellular domain which has enzymatic activity

A

Kinase-Linked & Related Receptors

18
Q

— all have large extracellular ligand-binding domain connected via single membrane spanning domain to an intracellular domain which has enzymatic activity

A

Kinase-Linked & Related Receptors

19
Q

What are the three major families of Kinase-Linked & Related Receptors?

A

— Receptor Tyrosine Kinases (RTKs)
— Serine/Threonine Kinases
— Cytokine Receptors

20
Q
— insulin receptor
* activates PI3 kinase 
pathway
» turns on or off gene 
expression
» activates glycogen 
synthesis
* activates Mitogen-
Activated Protein (MAP) 
Kinase pathway
» turns on or off gene 
expression
A

• Receptor Tyrosine

Kinases (RTKs)

21
Q
— smaller group than RTKs
— structurally and functionally very similar 
to RTKs
— phosphorylate serine and threonine 
instead of tyrosine
— e.g. transforming growth factor (TGF)
A

• Serine/Threonine Kinases

22
Q

— interleukins, interferons, chemokines,
etc
— lack intrinsic enzymatic activity in
intracellular domains!!
— associate and activate other kinases
* binds and activates Janus Kinase (Jak)
* Jak binds and activates Signal Transducers
and Activators of Transcription
» a.k.a. the “Jak-STAT” pathway
* downstream turns on or off gene expression

A

• Cytokine Receptors

23
Q
— ligand-activated transcription factors
— ligand examples:
* estrogens, progestins, androgens, 
glucocorticoids, mineralocorticoids, vitamin D, 
vitamin A (retinoid receptors), fatty acids, etc.
— two main locations in the cell
* cytoplasmic
* nuclear
— ligand-binding and DNA-binding domains
A

Nuclear receptor

24
Q

Of all receptor superfamilies, which one must have ligand get into cell to activate receptor?

A

Nuclear receptor

25
— cytoplasmic * most are bound to Heat Shock Proteins when no ligand is present * most form homodimers upon ligand binding (e.g. steroid receptors) * some form heterodimers with Retinoid X Receptor (e.g. thyroid hormone) * translocate to nucleus to regulate gene expression — nuclear (e.g. fatty acid receptors) * constitutively present in nucleus * form heterodimers with Retinoid X Receptor (RXR) — interact with hormone response elements on genes to regulate gene expression • Example: Androgen Receptors
• Nuclear Receptors (“Steroid Superfamily”)
26
— ______ that are key rate-limiting steps in biochemical reactions are the best drug targets — strategy is most often to reduce this activity through drug inhibition
enzymes
27
— competitively inhibit rate-limiting step in cholesterol biosynthesis in liver * liver upregulates LDL receptors thereby reducing plasma LDL concentrations
• HMG-CoA Reductase Inhibitors | “Statins”
28
— monoclonal antibodies that recognizes TNF-a | — bind TNF-a removing it from circulation
• Infliximab and adalimumab
29
* important in moving substances across lipid bilayer membranes * often good drug targets as they regulate key cellular events
Ion and Small Molecule Transporters
30
* neurotransmitter uptake (norepinephrine, 5-HT, glutamate, etc.) * organic ion transporters (organic acids and bases) * p-glycoprotein (Multi-Drug Resistance)
Small molecule transporters
31
— protective role in moving potential toxicants out of gastrointestinal epithelial cells back into lumen to prevent absorption — overexpressed in certain tumor cells leading to drug resistance — can be blocked by drugs * could increase absorption of some drugs * could potentially increase activity of anti-cancer drugs
• p-glycoprotein (Multi-Drug Resistance)
32
________ important everywhere — establishes electrochemical gradient by moving Na+ out and K+ in against concentration gradient — requires energy (ATP) to function — key in all muscle contraction, nervous conduction, ion gradient establishment, etc — often provides the driving force for other ion transporters — can be inhibited by drugs (e.g. digoxin, a cardiac glycoside used for heart failure)
• Na+/K+ ATPase
33
``` • structure — very similar in structure and function to ligand-gated ion channel receptors • Ca++ channels (L, T, N types) • Na+ channels (fast and slow types) • K+ channels (voltage- and ligand- gated types) — produce at least 9 different K+ currents in heart, vascular smooth muscle, and other tissues such as pancreas ```
Voltage-Gated Ion Channels
34
``` — channels open or close depending upon the electrical gradient (voltage) across the plasma membrane * resting membrane potential ~ -90 mV * depolarized membrane potential ~ 0 mV — channels change opened/closed or activated/resting states as electrical potential changes from -90 mV to +10 mV (inside relative to outside) — channels often susceptible to binding by various compounds, including xenobiotics ```
• voltage-dependent gated ion channels
35
— Ca++ Channel Blocker * binds to L-type Ca++ channels in heart and vascular smooth muscle * blocks movement of Ca++ from outside to inside * reduces cardiac contraction (negative inotropic effect) * slows cardiac conduction (negative chronotropic effect) * reduces vascular smooth muscle contraction * reduces blood pressure
Verapamil
36
______ inhibits L type Ca channel reduces heart rate and contractility
Verapamil